Research and Markets (http://www.researchandmarkets.com/research/pb82zj/us_peripheral) has announced the addition of the "US Peripheral Vascular Closure Devices Market - 2016" report to their offering.

The value of the total vascular closure device (VCD) market is expected to increase modestly over the forecast period. VCDs can be classified as invasive or non-invasive. Invasive VCDs operate by inserting a device component into the arterial hole and effecting closure by various mechanisms (including sutures, sealants and collagen sponges). Non-invasive VCDs act at the exterior of the skin to achieve hemostasis.

Vascular interventions often involve the introduction of a catheter into the peripheral system. For example, during a stent placement procedure, a small hole is created in the artery for access. If unmanaged, this access hole will bleed profusely. Therefore, some form of vascular closure is required. The standard procedure to manage post-procedure bleeding is manual compression.

Key Topics Covered:

1 Overview

1.1 Vascular Closure Device Market

2 Research Methodology

3 Vascular Closure Device Market

3.1 Introduction

3.2 Market Overview

3.3 Market Analysis And Forecast

3.3.1 Total Vascular Closure Device Market

3.3.2 Invasive Vascular Closure Device Market

3.3.3 Non-Invasive Vascular Closure Device Market

3.4 Drivers And Limiters

3.5 Competitive Analysis

Companies Mentioned

  • St. Jude Medical
  • Abbott Laboratories
  • Cardinal Health
  • Cardiva
  • Vascular Solutions
  • Marine Polymer Technologies
  • Advanced Vascular Dynamics
  • Arstasis
  • HemCon Medical Technologies
  • Morris Innovative, Inc.
  • TZ Medical

For more information visit http://www.researchandmarkets.com/research/pb82zj/us_peripheral.